Infliximab

• Infliximab is a biologic medication that targets tumor necrosis factor-alpha (TNF-alpha).
• It is primarily used to treat chronic inflammatory conditions such as Crohn’s disease, ulcerative colitis, and rheumatoid arthritis.
• The medication works by neutralizing TNF-alpha, a protein that promotes inflammation in the body.
• Administration is typically via intravenous infusion in a clinical setting.
• Common side effects include infusion reactions and an increased risk of infections.

What is Infliximab?

Infliximab is a chimeric monoclonal antibody that specifically binds to and neutralizes tumor necrosis factor-alpha (TNF-alpha), a cytokine that plays a central role in inflammatory processes. As a biologic therapy, it is manufactured using living organisms and targets specific parts of the immune system, unlike traditional small-molecule drugs. Its action helps to reduce inflammation and suppress the overactive immune responses characteristic of several chronic autoimmune diseases.

Developed to offer a more targeted approach to managing severe inflammatory conditions, Infliximab has significantly improved outcomes for patients who have not responded adequately to conventional treatments. It represents a class of medications known as TNF inhibitors, which are crucial in modern rheumatology and gastroenterology.

What is Infliximab Used For?

Infliximab is approved for the treatment of several chronic inflammatory and autoimmune conditions. Its ability to modulate the immune response makes it effective in reducing the signs and symptoms of diseases where TNF-alpha contributes significantly to pathology. Patients receiving infliximab treatment information often learn about its broad applications across different specialties.

The primary conditions for which Infliximab is prescribed include:

• Crohn’s Disease: A type of inflammatory bowel disease (IBD) affecting the digestive tract.
• Ulcerative Colitis: Another form of IBD characterized by inflammation and ulcers in the large intestine.
• Rheumatoid Arthritis: A chronic inflammatory disorder affecting joints, often leading to pain, swelling, and joint damage.
• Ankylosing Spondylitis: A form of arthritis primarily affecting the spine.
• Psoriatic Arthritis: A type of arthritis that affects some people with psoriasis.
• Plaque Psoriasis: A chronic skin condition causing red, scaly patches.

According to the Crohn’s & Colitis Foundation, biologics like Infliximab have revolutionized the treatment of inflammatory bowel diseases, significantly improving quality of life and reducing the need for surgery in many patients.

How Infliximab Works and Potential Side Effects

The mechanism by which Infliximab exerts its therapeutic effects involves its precise interaction with TNF-alpha. Once administered, Infliximab circulates in the bloodstream and binds to both soluble and transmembrane forms of TNF-alpha. By doing so, it prevents TNF-alpha from interacting with its receptors on cell surfaces, thereby blocking its inflammatory signaling pathways. This neutralization of TNF-alpha leads to a reduction in the production of other pro-inflammatory cytokines and a decrease in the migration of inflammatory cells to affected tissues, ultimately mitigating inflammation and tissue damage.

While highly effective, Infliximab treatment is associated with potential side effects, ranging from mild to severe. Understanding infliximab side effects is crucial for patients and healthcare providers. Common side effects often include:

• Infusion-related reactions (e.g., fever, chills, headache, rash)
• Upper respiratory tract infections (e.g., sinusitis, pharyngitis)
• Nausea and abdominal pain
• Headache
• Fatigue

More serious side effects, though less common, can include severe infections (e.g., tuberculosis, fungal infections), reactivation of hepatitis B virus, heart failure, liver problems, and certain types of cancer (e.g., lymphoma). Due to the potential for serious infections, patients are typically screened for tuberculosis and hepatitis B before starting treatment. Regular monitoring throughout the course of therapy is essential to manage and mitigate these risks effectively, ensuring patient safety and optimal treatment outcomes.